Tesamorelin is a synthetic growth hormone-releasing hormone (GHRH) analog specifically designed to stimulate the pituitary gland to release growth hormone (GH). It is FDA-approved for the treatment of HIV-associated lipodystrophy, particularly to reduce excess abdominal fat. By increasing endogenous growth hormone secretion, Tesamorelin helps improve body composition, reduce visceral fat, and promote overall health.

Key Benefits:

1. Reduces Visceral Fat: Tesamorelin is particularly effective in reducing abdominal fat accumulation, especially in HIV-associated lipodystrophy.

2. Improves Body Composition: By increasing GH levels, Tesamorelin helps enhance muscle mass while reducing body fat.

3. Promotes Metabolic Health: It aids in improving lipid profiles, reducing the risk of cardiovascular diseases.

4. Enhances Overall Well-Being: Increased GH levels contribute to higher energy levels, improved skin health, and tissue repair.

5. Supports Immune Function: For individuals with HIV, Tesamorelin may help improve immune function.

Target Audience:

• Individuals with HIV, particularly those experiencing lipodystrophy (e.g., abdominal fat accumulation).

• Individuals seeking to reduce visceral fat and improve body composition.

• Those aiming to enhance metabolic health and overall vitality.

---

Our factory

“Strength builds the foundation, and excellent services reach all over the world.” Create win-win situation with customers